Stannsoporfin

DB04912

small molecule investigational

Deskripsi

Stannsoporfin is a competitive heme oxygenase (HO) inhibitor being developed by InfaCare, a subsidiary of WellSpring Pharmaceuticals, for the prevention of hyperbilirubinemia in infants at risk of developing jaundice.

Struktur Molekul 2D

Berat 754.3
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 3.8 hours following i.v. administration of 1 mumole per kg body weight
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Not absorbed orally

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Target Protein

Heme oxygenase 1 HMOX1
Heme oxygenase 2 HMOX2

Referensi & Sumber

Artikel (PubMed)
  • PMID: 2714739
    Galbraith RA, Kappas A: Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyria. Hepatology. 1989 Jun;9(6):882-8.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Stanate

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul